Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in SYRE — Spyre Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$97,038,845
+$47,643,007 QoQ
Shares Held
1,093,026
+11.6% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 266 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. SYRE ranks #19 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in SYRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97,038,845 1,093,026
2026-03-31 $49,395,838 979,299
2025-12-31 $2,062,273 62,951
2025-09-30 $4,625,490 275,984
2025-06-30 $707,765 47,279
2025-03-31 $670,504 41,556
2024-12-31 $820,572 35,248
2024-09-30 $866,800 29,473
2024-06-30 $535,368 22,772
2024-03-31 $417 11
2023-12-31 $882 41
2023-09-30 $502 41